IMAB362
Astellas snatches up oncology firm Ganymed for $1.4 billion
October 31, 2016Research and Development, Sales and Marketing Astellas, Ganymed, IMAB362
Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
